Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/1996
12/12/1996WO1996039408A1 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO[3,4-c]-1,2,4-TRIAZOLO[4,3-α]PYRIDINES
12/12/1996WO1996039374A1 2,4-pentadienoic acid derivatives having retinoid-like biological activity
12/12/1996WO1996039372A2 Macrophage lipid chemoattractant
12/12/1996WO1996039152A1 Use of locally applied dna fragments
12/12/1996WO1996039119A1 Topical vehicles containing solubilized and stabilized azelaic acid
12/12/1996WO1996011949A3 Analogs of keratinocyte growth factor
12/12/1996CA2223957A1 Transforming growth factor alpha hi
12/12/1996CA2223383A1 Topical vehicles containing solubilized and stabilized azelaic acid
12/12/1996CA2222280A1 Human chemokine beta-11 and human chemokine alpha-1
12/12/1996CA2222040A1 Macrophage lipid chemoattractant
12/12/1996CA2218329A1 Fibroblast growth factor-11
12/11/1996EP0747353A2 Indole derivatives
12/11/1996EP0747062A2 Stable complexes of crosslinked polyvinylpyrrolidone and iodine and method of making the same
12/11/1996EP0747047A1 Combination of an antimicrobial compound (e.g. the lipoaminoacid N,n-octanoyl-glycine) and a monoalkylglycerol ether and its use as an antimicrobial agent
12/11/1996EP0747043A1 Use of salicylic acid derivatives for skin whitening
12/11/1996EP0747042A1 Compositions containing azole derivatives for topical application to skin
12/11/1996EP0747040A1 Petroleum jelly with inositol phosphates
12/11/1996EP0746612A1 Synthetic polynucleotides
12/11/1996EP0746547A1 2-(4-methoxyphenoxy)-3-pyridineamine, its preparation and its use as anti-inflammatory agent
12/11/1996EP0746324A1 Method of combatting osteoporosis and other disease states in mammalian subjects, utilizing organic boron compounds
12/11/1996EP0746294A1 Absorption enhancers for topical pharmaceutical formulations
12/11/1996EP0532512B1 Use of platelet activating factor antagonists as anti-pruritic agents
12/11/1996EP0521080B1 Synergistic compositions
12/11/1996CN1137564A Stable transglutaminase preparations and processes for producing them
12/11/1996CN1137413A Yuxianwan pill for curing psoriasis
12/11/1996CN1137410A Germicidal anti-inflammatory myogenic plaster for external use and preparation method thereof
12/11/1996CN1137391A Toxin-resolving plaster for curing carbuncle and furuncle and its preparation method
12/10/1996US5583222 Antiinflammatory agents for treatment of skin disorders
12/10/1996US5583154 Containing a 1,3-dithiolane compound
12/10/1996US5583152 Method for treating vasospastic cardiovascular diseases heterocyclic amide derivatives
12/10/1996US5583125 25-Carboxylic acid derivatives in the vitamin D series, process for their production, intermediate products for these processes, pharmaceutical preparations containing these derivatives as well as their use for the production of pharmaceutical agents
12/10/1996US5582832 Compositions for topical application to skin
12/10/1996US5582823 Methods of treating bacterial inflammation and granulocytopoiesis by administering human pluripotent granulocyte colony-stimulating factor
12/08/1996CA2173172A1 Petroleum jelly with inositol phosphates
12/05/1996WO1996038579A1 High-affinity oligonucleotide ligands to growth factors
12/05/1996WO1996038457A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
12/05/1996WO1996038426A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
12/05/1996WO1996038412A1 Novel compounds and anti-dermatitis drug
12/05/1996WO1996038172A1 Connective tissue growth factor
12/05/1996WO1996038168A1 Methods and uses of connective tissue growth factor as an induction agent
12/05/1996WO1996038162A1 Method of using lectins for prevention and treatment of skin diseases and disorders
12/05/1996WO1996038160A1 Extract from the leaves of ginkgo biloba
12/05/1996CA2223276A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
12/05/1996CA2222609A1 Methods and uses of connective tissue growth factor as an induction agent
12/05/1996CA2222147A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
12/04/1996EP0745375A1 Skin care compositions containing dimethyl imidazolidinone and retinol or retinyl ester
12/04/1996EP0745324A1 Stable micro-emulsions of certain 3-isothiazolone compounds
12/04/1996EP0745091A1 Use of angiotensin ii analogs in tissue repair
12/04/1996EP0745078A1 Enantiomerically pure(-)-liarozole
12/04/1996EP0745077A1 Enantiomerically pure (+)-liarozole
12/04/1996EP0745075A1 6-substituted mycophenolic and derivatives with immunosuppressive activity
12/04/1996EP0745074A1 4-amino derivatives of mycophenolic acid with immunosuppressant activity
12/04/1996EP0745073A1 5-substituted derivatives of mycophenolic acid
12/04/1996EP0745072A1 4-amino derivatives of 5-substituted mycophenolic acid
12/04/1996EP0745071A1 4-amino 6-substituted mycophenolic acid and derivatives with immunosuppressive activity
12/04/1996EP0745068A1 Heteroaryl-substituted deoxy glycero-phosphoethanolamines
12/04/1996EP0744956A1 Peptides and methods against diabetes
12/04/1996EP0684765A4 Treating alopecia by administering 5-alpha-reductase inhibiting compounds.
12/04/1996CN1137275A O-aryl O-alkyl O-alkenyl and O-alkynyl-macrolides having immunosuppressive activity
12/04/1996CN1137237A Method of treating androgenic alopecia with 5-alpha reductase inhibitors
12/04/1996CN1137037A Quinazoline derivatives
12/04/1996CN1136927A Medicine for treating mosquito and insect bite and preparing process thereof
12/03/1996US5580960 KS-laminin and methods of use
12/03/1996US5580865 2,2-disubstituted cephem sulphones
12/03/1996US5580755 Human pluripotent granulocyte colony-stimulating factor
11/1996
11/28/1996WO1996037515A1 Process of high purity albumin production
11/28/1996WO1996037489A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
11/28/1996WO1996037228A1 Antibacterial-wound healing compositions and methods for preparing and using same
11/28/1996WO1996037210A2 Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field
11/28/1996WO1996037201A2 METHODS AND COMPOSITIONS FOR INHIBITING 5α-REDUCTASE ACTIVITY
11/28/1996WO1996037193A1 Topically applicable agents for treating and preventing alopecia
11/28/1996WO1996037187A1 Cosmetic or dermatological preparations containing phytic acid
11/28/1996DE19519273A1 Topisch applizierbare Mittel zur Behandlung und Prophylaxe der Alopezie Topically applicable agent for the treatment and prophylaxis of alopecia
11/28/1996DE19518845A1 Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Phytinsäure Cosmetic or dermatological preparations containing phytic acid
11/28/1996CA2222061A1 Agents that can be administered topically for treatment and prophylaxis of alopecia
11/28/1996CA2222041A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
11/28/1996CA2221236A1 Methods and compositions for inhibiting 5.alpha.-reductase activity
11/27/1996EP0743944A1 Azacyclic derivatives
11/27/1996EP0563085B1 Novel compositions
11/27/1996CN1136808A Pseudodipeptide product having imidazole grouping and applications
11/27/1996CN1136568A New heterocyclic spiro compounds, process for preparation thereof, and pharmaceutical compositions containing them
11/27/1996CN1136557A Para retinoic acid
11/27/1996CN1136555A Nerve amide compound, its preparing method and its use
11/27/1996CN1033365C Preparing method for lipides composition containing scutellaria compound
11/26/1996US5578742 Inhibit uncontrolled cell proliferation, treatment of psoriasis, aids, cancer, antitumor
11/26/1996US5578724 Process for preparation of benzo[f]quinolinones
11/26/1996US5578612 Indole derivatives
11/26/1996US5578599 Stimulation of hair growth with minoxidil and a 5α-reductase inhibitor
11/26/1996US5578469 Process for preparing neotrehalose, and its uses
11/26/1996CA2078287C Nitroxides as protectors against oxidative stress
11/21/1996WO1996036709A1 Transforming growth factor alpha hii
11/21/1996WO1996036642A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/21/1996WO1996036625A1 Phenyl dihydrobenzofuranes
11/21/1996WO1996036324A2 Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions
11/21/1996WO1996036222A2 Improved method for controlling ectoparasites
11/21/1996CA2221357A1 Phenyl dihydrobenzofuranes
11/21/1996CA2220687A1 Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions
11/21/1996CA2219487A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/20/1996EP0743312A1 Spiroheterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
11/20/1996EP0742717A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
1 ... 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 ... 1065